BRCA 1/BRCA 2 Pathogenic/Likely Pathogenic Variant Patients with Breast, Ovarian, and Other Cancers

Autor: Osman K., Ahmet K., Hilmi T., İlker N.O., Ercan Ö., Devrim Ç., Murat S., Emre Ç., İlhan H., Mustafa G., Yüksel Ü., Bahiddin Y., Cihan E., Mehmet Ali N. Ş., Emrah E., Umut D., Zeynep O., Mehmet Ali K., Ali G., İvo G., Erkan Ö., Muhammet B.H., Bülent E., Selma D., Sernaz U., Mahmut G., Hakan G., İrfan Ç.

Publikováno v: Balkan Journal of Medical Genetics, Vol 25, Iss 2, Pp 5-14 (2022)

The demographic and clinical characteristics of patients who have BRCA 1/BRCA 2 pathogenic/likely pathogenic variants may differ from their relatives who had BRCA-related cancer. In this study, we aimed to demonstrate the clinical and demographic fin

Externí odkaz: https://doaj.org/article/c0cbaea0ff6d4a069d5e79ca2869ea80

BRCA 1/BRCA 2 Pathogenic/Likely Pathogenic Variant Patients with Breast, Ovarian, and Other Cancers.

Autor: Osman K; Marmara University, School of Medicine, Department of Medical Oncology, İstanbul, Turkey., Ahmet K; Trakya University, Department of Medical Oncology, Edirne, Turkey., Hilmi T; Namık Kemal University, Department of Medical Genetic, Tekirdag, Turkey., İlker NO; Medeniyet University, Department of Medical Oncology, İstanbul, Turkey., Ercan Ö; Kocaeli University, Department of Medical Oncology, Kocaeli, Turkey., Devrim Ç; Kocaeli University, Department of Medical Oncology, Kocaeli, Turkey., Murat S; Marmara University, School of Medicine, Department of Medical Oncology, İstanbul, Turkey., Emre Ç; Sakarya University, Department of Medical Oncology, Sakarya, Turkey., İlhan H; Sakarya University, Department of Medical Oncology, Sakarya, Turkey., Mustafa G; Ankara university, Department of Medical Oncology, Ankara, Turkey., Yüksel Ü; Ankara university, Department of Medical Oncology, Ankara, Turkey., Bahiddin Y; Ondokuz Mayıs University, Department of Medical Oncology, Samsun, Turkey., Cihan E; Ankara City Hospital, Yildirim Beyazit University, Department of Medical Oncology, Ankara, Turkey., Mehmet Ali NŞ; Ankara City Hospital, Yildirim Beyazit University, Department of Medical Oncology, Ankara, Turkey., Emrah E; University of Health Sciences, Dr. A.Y Ankara Oncology Research and Education Hospital, Oncology Department, Ankara, Turkey., Umut D; University of Health Sciences, Dr. A.Y Ankara Oncology Research and Education Hospital, Oncology Department, Ankara, Turkey., Zeynep O; Dicle University, Department of Medical Oncology, Diyarbakır, Turkey., Mehmet Ali K; Trakya University, Department of Medical Genetic, Edirne, Turkey., Ali G; Trakya University, Department of Medical Oncology, Edirne, Turkey., İvo G; Trakya University, Department of Medical Oncology, Edirne, Turkey., Erkan Ö; Trakya University, Department of Medical Oncology, Edirne, Turkey., Muhammet BH; Trakya University, Department of Medical Oncology, Edirne, Turkey., Bülent E; Trakya University, Department of Medical Oncology, Edirne, Turkey., Selma D; Trakya University, Department of Medical Genetic, Edirne, Turkey., Sernaz U; Trakya University, Department of Medical Oncology, Edirne, Turkey., Mahmut G; Medeniyet University, Department of Medical Oncology, İstanbul, Turkey., Hakan G; Trakya University, Department of Medical Genetic, Edirne, Turkey., İrfan Ç; Trakya University, Department of Medical Oncology, Edirne, Turkey.

Publikováno v: Balkan journal of medical genetics : BJMG [Balkan J Med Genet] 2023 May 02; Vol. 25 (2), pp. 5-14. Date of Electronic Publication: 2023 May 02 (Print Publication: 2023).